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Lawsonia intracellularisAbstract Porcine proliferative enteropathy (PPE) is a common and economically important
gastro-intestinal disease of swine caused by the intracellular bacterium, Lawsonia intracellularis.
Conventional tests to detect antibody responses to L. intracellularis include the immuno-peroxidase
monolayer assay (IPMA), immuno-ﬂuorescent antibody test (IFAT) and a lipopolysaccharide
ELISA (LPS-ELISA). These tests are not commercially available. Therefore, objective of this study
is to evaluate the performance of a commercial L. intracellularis blocking ELISA. Performance of
the commercial ELISA was compared to the IPMA and LPS-ELISA using serum from experimen-
tally infected animals (N= 40). The prevalence of L. intracellularis sero-positive animals was
assessed by comparing suspect and randomly selected sera (N= 394). The commercial ELISA,
IPMA and a non-commercial lipopolysaccharide (LPS) LPS-ELISA showed a 95% correlation
when tested using experimentally derived known status samples. When compared to the IPMA
the sensitivity of the commercial ELISA was 91% while the speciﬁcity was 100%. Therefore, the
diagnostic sensitivity and speciﬁcity of the commercial L. intracellularis ELISA was comparable
to the LPS-ELISA and IPMA. A comparison of suspect and randomly selected ﬁeld samples with
the commercial ELISA indicated that L. intracellularis sero-positivity is widespread and does not
correlate with possible disease status.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Faculty of Veterinary Medicine, Cairo
University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/3.0/).r assay;
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Porcine proliferative enteropathy (PPE), also known as ileitis,
is an important production disease of growing piglets. The eti-
ological agent of PPE is Lawsonia intracellularis, an obligate
intracellular bacterium that colonizes the intestinal epithelial
cells leading to thickening and proliferation of crypt cells.
Therefore, characteristic histopathology consists of the pres-
ence of proliferative lesions in the mucosa of the small and large
intestine [1–3]. Growing piglets are commonly affected by PPE.
Naı¨ve adults experience the acute form of the disease. PPE is
characterized by brownish diarrhea, loss of condition and poor
weight gain resulting in signiﬁcant economic losses [4,5]. While
the exact estimates for the sero-positivity of L. intracellularis in
swine production areas in the U.S. are not available, PPE is
present worldwide in pork production systems [4,6].
Immunohistochemistry (IHC) is a routine procedure for
post-mortem diagnosis of PPE [7]. Polymerase chain reaction
(PCR) based tests are available for the detection of L. intracell-
ularis in fecal material. However, these tests are relatively more
expensive than serology and have variable sensitivity [8–10].
With the introduction of an attenuated, live porcine ileitis vac-
cine in the U.S. market [11], ante-mortem detection and diagno-
sis of PPE, particularly by serology, has gained practical utility.
Serology is an important tool in understanding the infection
kinetics in herds. Seroproﬁles are necessary to better position
vaccination and/or medication strategies in herds with prolifer-
ative enteropathy problems as the optimal time for vaccine
placement is after the maternal antibodies have waned [12].
Traditional culture methods for L. intracellularis are cum-
bersome and time-consuming. Yet, an indirect immunoﬂuores-
cence assay (IFA) or immuno-peroxidase monolayer assays
(IPMA) were the only available tests [7,13,14] in diagnostic lab-
oratories to detect antibody responses to L. intracellularis until
a lipopolysaccharide (LPS) based ELISA was developed (LPS-
ELISA). However, the LPS-ELISA is not commercially avail-
able [15]. A commercial monoclonal antibody based blocking
ELISA became available a few years ago [16]. The manufac-
turer- claimed performance metrics for this assay included a
sensitivity of 96.5% and speciﬁcity of 98.7%. However, only
one report comparing the performance of the commercial
ELISA to the IFAT, which is not widely available, is published
so far [17]. Therefore, in this study we have evaluated the per-
formance of the commercial ELISA by comparing its perfor-
mance with assays such as the IPMA and LPS ELISA.
2. Materials and methods
2.1. Serum samples for assay veriﬁcation
Forty swine sera of known status collected from experimen-
tally infected animals were provided by Boehringer Ingelheim
Vetmedica, Inc. (BIVI). Twenty of these were collected from
infected animals while the other twenty were from uninfected
controls. Post-infection antibody responses were conﬁrmed
by IFAT as described by Kroll et al., [15]. To determine if
the presence of clinical signs correlated with sero-positivity, a
total of 308 ﬁeld samples derived from eight case submissions
to the Iowa State University Veterinary Diagnostic laboratory
were tested by the commercial ELISA (bioScreen Ileitis
Antibody ELISA, Synbiotics Corporation, Lyon, France).The selected cases were suspect for ileitis due to a case history
of diarrhea and loss of condition in the affected animals. To
determine the general population prevalence, 86 other ﬁeld
samples were blinded to case history and randomly selected
for analysis by the commercial ELISA.
2.2. Comparison of the performance of the commercial ELISA,
IPMA and LPS ELISA
Antibodies against L. intracellularis in the experimental,
known-status samples were detected by two independent diag-
nostic laboratories either by an LPS based ELISA [15] or an
IPMA [13,14]. Inter-assay variation for the commercial ELISA
was measured by three independent assessments of the experi-
mental known status samples. To determine whether the rate
of sero-positivity correlated with possible disease status, sus-
pect and random ﬁeld samples were evaluated by the commer-
cial ELISA.
2.3. Commercial L. intracellularis ELISA
Testing with the commercial ELISA kit (bioScreen Ileitis Anti-
body ELISA, Synbiotics Corporation, Lyon, France) was car-
ried out following manufacturer’s instructions. The
commercial ELISA kit contains L. intracellularis antigen
which is immobilized on a 96 well ELISA plate. Following
the kit protocol, swine serum or plasma samples are placed
in the wells. Following incubation and wash steps, a monoclo-
nal antibody conjugated to peroxidase speciﬁc to an L. intra-
cellularis epitope, is added to the wells. If the sample
contains anti-L. intracellularis antibodies, the antigenic sites
are blocked thus preventing binding of the monoclonal anti-
body conjugate. Therefore, color development is either very
low or absent. If the sample does not contain anti-L. intracell-
ularis antibodies, the antigen is free to bind to the monoclonal
antibody resulting in intense color development. The optical
density is measured at 450 nm in a microplate reader and the
percent inhibition (PI) of the positive controls and test samples
relative to the negative controls is calculated. Any serum sam-
ple presenting a PI ofP30% is considered positive. Any sam-
ples presenting a PI of 620% are considered negative. Samples
within 20–30% range are considered suspects.
2.4. Statistical analysis
For the experimental samples, the agreement between the com-
mercial ELISA and the LPS based ELISA was assessed by the
Pearson’s correlation coefﬁcient with a raw continuous scale
using the PI values. The dichotomous agreement between the
commercial ELISA, the LPS based ELISA and the IPMA
was measured by kappa coefﬁcients. The sensitivity, speciﬁcity,
positive and negative predictive values of the commercial
ELISA was determined by standard formulae.
3. Results
3.1. Comparative detection of known-status samples on the
commercial ELISA, LPS ELISA and IPMA
All of the twenty known status negative samples were negative
when tested with the commercial ELISA, LPS ELISA and
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positive using IPMA while, nineteen were positive with the
LPS ELISA and 18 were positive using the commercial
ELISA. Two known-status positive samples showed a variable
reaction on the commercial ELISA with one sample being neg-
ative on two runs and suspect on the third. This sample was
also negative on the LPS ELISA while it was positive on the
IPMA. The second sample was negative on two runs, positive
on the third and positive on both the LPS ELISA and IPMA.
Both of these samples had PI values that were either high neg-
atives or low positives and therefore could be considered ‘grey
zone’ samples which are neither clearly positive nor negative at
the time of collection, probably because of ongoing sero-
conversion in the host (Fig. 1).
The commercial ELISA showed consistent performance
and very little intra-assay variation when the PI values over
three independent assays was compared as Pearson’s
correlation coefﬁcients. Similarly, the average correlation coef-
ﬁcient between the commercial ELISA and the LPS ELISA
was 0.92 (Table 1). When the results were compared between
the three assays as kappa coefﬁcients, the lowest agreement
between the three replicate values on the commercial ELISA
and between the three tests was 0.95, indicating that all three
tests were comparable to each other in performance (Table 2).
3.2. Sensitivity and speciﬁcity assessment
As all the known status samples were correctly identiﬁed by
the IPMA, its accuracy, sensitivity and speciﬁcity was 100%.
When the IPMA was used as the comparative test, the sensitiv-
ity of the commercial ELISA was 91% while the speciﬁcity was
100%. The sensitivity of the LPS ELISA was 95% while the
speciﬁcity was 100%. The LPS ELISA was 97.5% accurate.
Therefore, the positive predictive values for all three tests were
100% while the negative predictive values for the commercial
ELISA was 90% and 95% for the LPS ELISA respectively.0
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Figure 1 Comparison of the detection of experimentally derived,
samples of known status by three different serological tests for L.
intracellularis. Twenty known positive and twenty known negative
samples were assessed on either a commercial ELISA, an LPS
based ELISA or IPMA. The graph shows results as the number of
positive, suspect and negative samples. The correct status of 95%
of samples was detected consistently by all three tests with the
IPMA showing 100% accuracy.3.3. Assessment of ﬁeld samples by the commercial ELISA and
IPMA
Forty-seven percent of the samples from the L. intracellularis
suspect cases were positive on the commercial ELISA while
44% were negative and 9% were suspect (Table 3). Among
the randomly selected samples approximately 66% were posi-
tive, 26% were negative and 8% were suspect (Table 3). Only
one case from each data-set was completely negative.
4. Discussion
Ante-mortem diagnosis of PPE has become increasingly
important in the prevention and control of this economically
important disease. Molecular methods such as PCR assays
are available. A real-time PCR assay had a sensitivity of only
0.84 and speciﬁcity of 0.93 in detecting L. intracellularis
infected swine feces. Therefore PCRs are not only less sensi-
tive, expensive and require specialized facilities and equipment
[7,10,18] but also have little value in predicting the optimal
time for vaccine placement. Serological methods are relatively
inexpensive and user-friendly and therefore are the ﬁrst
method of choice in screening swine herds for antibodies
against L. intracellularis.
The IPMA is the gold standard for serological diagnosis of
PPE but plate preparation is cumbersome and the procedure
has subjectivity. ELISA test formats have the greatest ease of
use and high throughput required for herd screening [15,19].
With the recent availability of a commercial ELISA a re-eval-
uation and comparison of assay performance between previ-
ously available assays and the commercial assay is important
to ensure accurate serological diagnosis of PPE.
In this study three successive runs of experimentally derived,
samples of known status resulted in excellent repeatability with
the commercial ELISA. In the assessment with the experimental
samples the IPMA was marginally more sensitive than both of
the ELISA’s tested as all known status samples were correctly
detected as either positive or negative by this test (Fig. 1,
Table 1). The commercial ELISA and the LPS-ELISA were
slightly less sensitive in detecting ‘grey zone’ samples (91%
and 95%, respectively) but did not detect false positives. These
results were in agreement with ﬁndings by others showing that
the IPMA is highly speciﬁc and sensitive [13,14]. As the immu-
noﬂuorescence antibody test (IFAT) is comparatively less spe-
ciﬁc and prone to false positive results and less commonly
available, this method was not included for assessment in this
study. Moreover, the performance of the commercial ELISA
has been compared to the IleiTest IFAT (ElancoAnimalHealth,
Indianapolis, Indiana, USA) [17]. In this study, when compared
to the IFAT, the sensitivity of the blocking ELISA was 72%,
speciﬁcity was 93%, the positive predictive value was 0.82 and
the negative predictive value was 0.89.
The ﬁndings of the current study that the LPS ELISA was
95% sensitive while the speciﬁcity was 100% and the accuracy
was 97.5% was a slightly lower estimation when compared to
the original study which showed a 99.5% sensitivity, probable
due to the smaller number of known status samples used [15].
Although the LPS ELISA is a useful serological tool in early
detection of L. intracellularis in swine, the need for puriﬁed
antigen make the cost of the ELISA prohibitive. In contrast,
the IPMA showed a higher sensitivity and speciﬁcity of
Table 2 Assessment of agreement as kappa coefﬁcients for the Lawsonia intracellularis serological tests*.
ELISA 1st replicate ELISA 2nd replicate ELISA 3rd replicate LPS-ELISA IPMA
ELISA
1st replicate
1
1
0.975
0.949
0.975
0.949
0.950
0.900
ELISA
2nd replicate
0.975
0.949
0.975
0.949
0.950
0.900
ELISA
3rd replicate
1
1
0.975
0.950
LPS-ELISA 0.975
0.950
* Commercial ELISA, LPS-ELISA – lipopolysaccharide ELISA, IPMA – immuno-peroxidase monolayer assay.
 Agreement percentage of dichotomous values derived from three commercial ELISA replicates, the LPS ELISA and the IPMA, kappa
coefﬁcients with a sample size of N= 40.
Table 3 Percentage of sero-positive animals in eight diagnos-
tic cases suspect for Lawsonia intracellularis (N= 308) as well
as six randomly selected cases blinded to case history
(N= 86)*.
Case type Positives Negatives Suspects
D-1 5/50 (10%) 40/50 (80%) 5/50 (10%)
D-2 88/180 (49%) 70/180 (39%) 22/180 (12%)
D-3 10/10 (100%) 0/10 (0%) 0/10 (0%)
D-4 0/10 (0%) 10/10 (100%) 0/10 (0%)
D-5 15/30 (50%) 14/30 (47%) 1/30 (3%)
D-6 10/10 (100%) 0/10 (0%) 0/10 (0%)
D-7 10/10 (100%) 0/10 (0%) 0/10 (0%)
D-8 6/8 (75%) 1/8 (12.5%) 1/8 (12.5%)
Total – D 144/308 (47%) 135/308 (44%) 29/308 (9%)
R-1 7/10 (70%) 0/10 (0.00%) 3/10 (30%)
R-2 0/18 (0.00%) 18/18 (100%) 0/18 (0.00%)
R-3 11/19 (58%) 4/19 (21%) 4/19 (21%)
R-4 29/29 (100%) 0/29 (0.00%) 0/29 (0.00%)
R-5 1/1 (100%) 0/1 (0.00%) 0/1 (0.00%)
R-6 9/9 (100%) 0/9 (0%) 0/9 (0%)
Total – R 57/86 (66.28%) 22/86 (25.58%) 7/86 (8.14%)
* Diagnostic cases suspected to involve Lawsonia intracellularis
shown as D-1, D-2 and so on. Random cases with blinded history
shown as R-1, R-2 and so on.
Table 1 Performance of the commercial enzyme linked immunosorbent assay (ELISA)*.
ELISA 1st replicate ELISA 2nd replicate ELISA 3rd replicate LPS-ELISA
1st replicate 1.00 0.99 0.98 0.91
2nd replicate 0.99 1.00 0.97 0.90
3rd replicate 0.98 0.97 1.00 0.95
LPS-ELISA 0.91 0.91 0.95 1.00
* ELISA – commercial ELISA, LPS-ELISA – lipopolysaccharide ELISA.
 Pearson correlation coefﬁcients with a sample size N= 40.
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study [13]. The commercial ELISA has a manufacturer claimed
sensitivity and speciﬁcity of 96.5 and 98.7% [16]. However, the
current study found that the sensitivity was slightly lower at
91% and the speciﬁcity was higher at 100% with experimen-
tally derived samples of known status and higher than the val-
ues reported by Jacobson et al.’s comparison to the IFAT [17].In the assessment of ﬁeld samples, a majority of the herds
examined were sero-positive for L. intracellularis. Surprisingly,
there were no signiﬁcant differences between samples from
PPE-suspect cases and randomly assigned samples which rep-
resented the baseline population in our study. A possible rea-
son for the lower sero-prevalence levels in the suspect samples
when compared to the random samples is that the clinical signs
of enteritis in the suspect samples could have been caused by
other common agents such as the transmissible gastro-enteritis
virus, rota virus or due to nutritional and metabolic reasons.
The ﬁndings in this study also indicate that sero-prevalence
is widespread and unless a quantitative assessment is carried
out by testing paired samples, ELISA results cannot be used
as an indicator of disease status. Although the current study
was not speciﬁcally designed to determine the rates of sero-
prevalence in the region, it would have been enhanced by cor-
relating age with sero-conversion in positive herds. However,
the study of these parameters is beyond the scope of this study.
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